# A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

> **NCT00116103** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Tacrolimus Inhalation Aerosol

## Key facts

- **NCT ID:** NCT00116103
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116103, "A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00116103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*